Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.56% | 7.32% | -0.86% | 4.52% | 13.48% |
| Total Depreciation and Amortization | 4.11% | -1.89% | -10.53% | -13.33% | -15.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.56% | 156.45% | 122.95% | -11.26% | 49.21% |
| Change in Net Operating Assets | 21.96% | -24.75% | -446.67% | -236.11% | -81.07% |
| Cash from Operations | 64.87% | 5.08% | 3.37% | -28.62% | -42.21% |
| Capital Expenditure | -3.87% | 3.13% | -48.53% | 2.33% | -4.32% |
| Sale of Property, Plant, and Equipment | -25.00% | 58.82% | -80.00% | -93.75% | 200.00% |
| Cash Acquisitions | -- | -- | -28.90% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 257.06% | 175.16% | 261.86% | -84.38% | 89.51% |
| Cash from Investing | -1,600.38% | 4,355.00% | -15.23% | -13.83% | 74.04% |
| Total Debt Issued | 98.13% | -- | -- | 100.00% | 135.68% |
| Total Debt Repaid | -68.50% | 48.60% | 46.07% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -50.00% | 96.30% | -- | -- | 33.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.72% | -8.72% | -8.67% | -8.72% | -10.37% |
| Other Financing Activities | -11.11% | 635.29% | -105.97% | -220.00% | -58.72% |
| Cash from Financing | 1,171.57% | 196.18% | 46.89% | -761.74% | 94.40% |
| Foreign Exchange rate Adjustments | 110.81% | 97.80% | -142.86% | 2,173.33% | 68.18% |
| Miscellaneous Cash Flow Adjustments | -200.00% | -- | -- | -100.00% | -- |
| Net Change in Cash | -5,099.24% | 1,348.89% | -6.80% | -72.69% | 105.12% |